News for Healthier Living

SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study

First dose at Rad Net, in partnership with Helios Clinical and The Oncology Institute of Hope and Innovation, in FAPI-GO trial for gastroesophageal cancers A second trial focused on PDAC, FAPI-PRO, launched December 2025

December 29, 2025


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025